WallStreetZenWallStreetZen

How to Buy Biote Stock

Biote Corp

biote Corp. operates in medical practice-building business within the hormone optimization space.

Biote stock last closed at $5.40, up 2.47% from the previous day, and has decreased 40.13% in one year. It has underperformed other stocks in the Medical Care Facilities industry by 0.34 percentage points. Biote stock is currently +170% from its 52-week low of $2.00, and -25.52% from its 52-week high of $7.25.

As of May 26, 2023, there are 70.71M shares of BTMD outstanding. The market cap of BTMD is $381.86M. In the past 24 hours, 42,506 BTMD shares were traded.

How to Buy Biote Stock

Wondering how to invest in Biote stock? Here's how.
  1. Choose where to buy Biote stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Biote stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Pick your method of payment and add your details.
  4. Evaluate Biote stock: The Biote ticker symbol is BTMD. Is Biote stock a good investment? Should you buy shares of BTMD? How do BTMD's underlying business fundamentals look? Do top analysts think Biote is a good buy? Why has BTMD's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if BTMD is a good stock to buy).
  5. Make your BTMD purchase: Decide if you will purchase BTMD shares at the current market price or use a limit order to purchase BTMD shares at a specific price.
  6. Get the latest news on your investment in BTMD: Create a watchlist to get the latest news on your position in Biote stock.

Step 1: Choose where to buy Biote stock

You will need a brokerage account to access the NASDAQ market and buy BTMD stock.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world financial markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've chosen the best brokerage, the next step is to fill out some personal details so you are able to buy BTMD stock today.

How to Open a New Account on eToro

  1. Click here to get started.
  2. Provide your personal details to create a new trading account.
  1. Submit your data by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your investment account

Now that you've created your account on one of the most highly reviewed stock apps, your next step is to transfer the money for your investment:

Check out this video walkthrough for more details depositing funds into your investment account.

Get started with eToro today

Step 4: Evaluate Biote stock

Once you have figured out the best place to buy Biote stock, it's critical to research their stock before you buy, so you actually comprehend the risk and opportunity.

Biote stock data

BTMD Price
$5.40
1w %
-5.01%
1y %
-40.13%
5y %
N/A
P/E
-10.59x
P/B
-7.87x
P/S
0.55x
PEG
N/A
Revenue
$172.66M
Earnings
-$7.77M
Fore. Rev. Growth
9.65%
Fore. Earn. Growth
N/A
Market Cap
$381.86M
Next Earnings
N/A
Next Dividend
N/A

Biote Overview

WallStreetZen was built to help everyday investors do more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on BTMD's stock page.

What is the fair value of BTMD stock?

Analysts use many financial metrics, analyses, models, and charts to gauge BTMD's intrinsic value.

You can do additional valuation analysis on BTMD's stock here.

BTMD Financial Health

Pros:

  • BTMD has cash burn of 4870000. It has enough cash and short-term investments to cover this for at least one year.
  • BTMD has $87.61M in cash and short term investments. This is enough to cover its annual cash burn of $4.87M.
  • There are more short-term assets than short-term liabilities on the BTMD balance sheet.

Cons:

  • Total BTMD debt is still negative.
  • There are more long-term liabilities than short-term assets on the BTMD balance sheet.
  • BTMD debt to equity ratio of -4.18 is negative.
  • BTMD profit margin has gone down from 22.8% to -4.5% in the past year.

Is Biote stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 1 Equities analysts who track BTMD, the consensus analyst rating on BTMD is a Strong Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Most Recent BTMD Analyst Ratings

George Kelly, a top 29% analyst from Roth MKM maintains BTMD with a strong buy rating and raises their BTMD price target from $10.00 to $11.00, on Mar 30, 2023.

Maintaining his Strong Buy rating, Kelly raised his price target on Biote Corp. by 10% following the release of the company's Q4 and FY 2022 earnings report on 2023/03/28.

The company's Q4 results and management's guidance were better than expected, the analyst summarized.

The stock remains inexpensive at just 6.3x the anticipated FY 2023 EBITDA, and management increased the size of the company's sales force by 50% in 2022, Kelly added.

Biote reported:

For Q4 2022:

  • EPS of $0.18.
  • Revenue of $44.5M which beat, by 18.5%, Q4 2021's $37.5M.
  • EBITDA of $13.1M which beat, by 40%, Q4 2021's $9.4M.

For FY 2022:

  • Loss per Share of $0.12.
  • Revenue of $165M which beat, by 18.3%, FY 2021's $139.3M.
  • EBITDA of $50.1M which beat, by 24.6% increase FY 2021's $40.2M.

For FY 2023, management guided:

  • Revenue of $190M to $200M.
  • EBITDA of $56M to $60M.

CEO Terry Weber commented: “Our financial performance reflected successful execution of our growth strategy, as we further built our sales team and practitioner network in both existing and new geographic markets.

“In early January, we successfully completed a secondary offering of Biote Class A common stock, representing an important milestone in our journey as a public company. This transaction not only significantly increased the liquidity of our publicly traded shares, but also broadened institutional ownership of our shares. As a management team, we remain focused on building long-term shareholder value through profitable growth.

"In 2023 we anticipate continued growth in both revenue and adjusted EBITDA, as we further build our market presence and practitioner network. We are investing to strengthen our infrastructure and capabilities while continuing to expand our sales team.

"Our 2023 financial forecast assumes stronger revenue growth and adjusted EBITDA performance in the second half of the year as we begin to benefit from the contributions of sales personnel added at the end of last year."

You can dive deeper into what analysts are projecting on the Biote stock forecast page.

BTMD Technical Indicators

SMA10
5.53
SMA20
5.83
SMA50
5.73
SMA100
5.05
SMA200
4.61
MACD
-0.14
MACD Signal
-0.05
MACD Histogram
-0.08
RSI
43.42
Stochastic %K
9.54
Stochastic %D
9.38
StochRSI %K
6.25
StochRSI %D
3.09

BTMD Earnings

Last year, BTMD revenue was $172.66M. In the last one years, BTMD's revenue has gone up by 19.08% per year. This was faster than the Medical Care Facilities industry average of 9.35%.

Dig into BTMD's earnings and revenue performance here.

Are BTMD executives and large shareholders buying or selling the stock?

In the past 12 months, executives and large shareholders at BTMD have sold more shares than they have bought.

Mary Elizabeth Conlon, General Counsel of BTMD, was the latest BTMD insider to sell. They sold $64,386.98 worth of BTMD shares on Apr 4, 2023.

Get more info about who owns BTMD shares here.

Does BTMD stock generate passive income?

No, Biote doesn't provide an income stream by paying out dividends.

What others are saying about BTMD

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Make your BTMD purchase

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a particular price, place a limit order.

Hit the Open button and eToro will place your order.

If you want more assistance investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest news on your investment in BTMD

Now that you own some BTMD shares, you'll want to stay up-to-date on your investment.

Put BTMD on a watchlist to get notified of the latest news about your BTMD stock.

BTMD Feed

How to Buy Stock in Biote

To reiterate, here are the 6 steps for buying Biote stock:

  1. Choose where to buy Biote stock
  2. Create your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Biote stock
  5. Make your BTMD purchase
  6. Get the latest news on your investment in BTMD

If you require a brokerage account, eToro is our favorite option.

Get Started with eToro Today

If you would like to get notifications regarding your investment in Biote, click below.

NASDAQ: BTMD
$5.40+0.13 (+2.47%)
Updated May 26, 2023
Open eToro Account
NASDAQ: BTMD
$5.40+0.13 (+2.47%)
Updated May 26, 2023
Open eToro Account

FAQ

How much does it cost to buy one Biote share?

As of May 26, 2023, it costs $5.40 to buy one share of Biote stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.37 shares of BTMD.

Get Started with eToro Today

Is now a good time to buy Biote stock?

According to 1 Wall Street analysts who monitor Biote, their consensus recommendation is to buy Biote stock.

What is the best way to buy Biote stock?

One way to place an order for Biote stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.